.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Others
- Spotlight

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Tech
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Start-Up
Planet
Others

home
Topic
Sun pharma acquisition

Sun Pharma Acquisition

SBI

SBI Joins 10 Global Lenders in Sun Pharma's Organon Financing Deal

BY Outlook Business Desk

Sun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?

Sun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?

BY Outlook Business Desk

Sun Pharma Shares Climb Nearly 4% Post Earnings Announcement

Sun Pharma Shares Climb Nearly 4% Post Earnings Announcement

BY PTI

Sun Pharma Gets DCGI Nod to Market Generic Semaglutide Injection

Sun Pharma Gets DCGI Nod to Market Generic Semaglutide Injection

BY PTI

Sun Pharmaceutical Reopens Talks With Organon, Eyes Historic $10 Bn Overseas Pharma Deal

Sun Pharma Likely to Buy Organon for $10 Bn

BY Outlook Business Desk

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

Sun Pharma To Acquire Remaining 21.52% Shares Of Taro For Rs 2,892 Crore

BY Press Trust of India

Zydus, Sun Pharma Ink Licensing Pact To Co-Market CKD Treatment Drug

Zydus, Sun Pharma Ink Licensing Pact To Co-Market CKD Treatment Drug

BY Press Trust of India

Advertisement

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

BY Press Trust of India

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.